Presentation is loading. Please wait.

Presentation is loading. Please wait.

Tracheal regeneration: Evidence of bone marrow mesenchymal stem cell involvement  Agathe Seguin, MD, PhD, Sonia Baccari, MD, Muriel Holder-Espinasse, MD,

Published byDonna Thomas Modified over 5 years ago

Similar presentations

Presentation on theme: "Tracheal regeneration: Evidence of bone marrow mesenchymal stem cell involvement  Agathe Seguin, MD, PhD, Sonia Baccari, MD, Muriel Holder-Espinasse, MD,"— Presentation transcript:

1 Tracheal regeneration: Evidence of bone marrow mesenchymal stem cell involvement 
Agathe Seguin, MD, PhD, Sonia Baccari, MD, Muriel Holder-Espinasse, MD, PhD, Patrick Bruneval, MD, Alain Carpentier, MD, Doris A. Taylor, PhD, Emmanuel Martinod, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 145, Issue 5, Pages e2 (May 2013) DOI: /j.jtcvs Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Perioperative view showing (A) stent insertion and (B) graft implantation. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 Macroscopic examination at 15 months after transplantation group showing moderate retraction and “rings” over the outer surface of graft. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

4 Figure 3 Graft at 3 months from injection group. A, Hematoxylin-eosin-saffron stain (original magnification ×10) showing anastomosis localization with epithelial regeneration and new cartilage in formation. B, Orcein stain (original magnification ×10) showing elastic fibers within the cartilage island. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

5 Figure 4 Hybridization in situ for the RNA of green fluorescent protein (GFP) for the transplanted and injected groups showing positive detection within the graft and inside the new cartilage. Left, Sense probe detection; right, antisense probe detection. A, Graft at day 21 from transplantation (original magnification ×5) showing GFP-positive cells clearly through the epithelial layer (arrows) and at lower levels inside the graft, decreasing with depth. B, Graft at 1.5 months from injection (original magnification ×10) showing GFP-positive cells through the connective tissue in graft depth under the epithelial layer. C, Graft at 6 months from injection (original magnification ×10) showing GFP-positive cells in the active border (arrows) of recipient cartilage (asterisk) near the anastomosis. D, Graft at 9 months from injection (original magnification ×10) showing GFP-positive cells in the active border (arrows) of cartilage of recipient cartilage (asterisk) near the anastomosis. E, Graft at 15 months from injection (original magnification ×10) showing GFP-positive cells clearly through the epithelial layer (arrows) and at lower levels inside the graft, decreasing with depth near cartilage (asterisk). The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

6 Figure 5 Hybridization in situ for the Y chromosome for graft at Left, 6 and Right, 9 months from injection (group 2; original magnification ×10). Positive epithelial cells for the Y chromosome (arrows) can be clearly seen, as well as positive cells inside the graft. (Labeling appears as a small white spot inside each cell.) The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

7 Figure E1 Macroscopic examination at 3 months for control group showing moderate retraction and integrated graft. Arrows indicate graft limits. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

8 Figure E2 Macroscopic examination at 15 months from injection showing moderate retraction and integrated graft. Arrows indicate graft limits. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

9 Figure E3 Graft at 3 months for control group. A, Hematoxylin-eosin-saffron stain (original magnification ×10). Epithelial regeneration (arrows) with elastic fibers present in the deep part of graft. B, Orcein stain (original magnification ×10) for elastic fiber detection (asterisk). The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

10 Figure E4 Graft at 12 months for control group showing ciliated epithelial regeneration (hematoxylin-eosin-saffron stain, original magnification ×40). The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

11 Figure E5 Hybridization in situ for RNA of green fluorescent protein (GFP) for the transplanted and injected group showing positive detection within the graft and inside new cartilage. Left, Sense probe detection; right, antisense probe detection. A, Graft at 1.5 months from injection (original magnification ×20) showing GFP-positive cells through the connective tissue in the graft depth under epithelial layer. B, Graft at 1.5 months from injection (original magnification ×20) showing GFP-positive cells in the active border (arrows) of recipient cartilage (asterisk). The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

12 Figure E6 Hybridization in situ for the Y chromosome for graft at 6 months from injection (group 2; original magnification ×40). Positive epithelial cells for the Y chromosome (arrow) and positive cells inside the graft can be clearly seen. (Labeling appears as a small white spot inside each cell.) The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Download ppt "Tracheal regeneration: Evidence of bone marrow mesenchymal stem cell involvement  Agathe Seguin, MD, PhD, Sonia Baccari, MD, Muriel Holder-Espinasse, MD,"

Similar presentations

Manuel J. Antunes, MD, PhD, DSc 

Manuel J. Antunes, MD, PhD, DSc 
Mycoplasma hominis prosthetic valve endocarditis: The value of molecular sequencing in cardiac surgery  Syed T. Hussain, MD, Steven M. Gordon, MD, Carmela.

Mycoplasma hominis prosthetic valve endocarditis: The value of molecular sequencing in cardiac surgery  Syed T. Hussain, MD, Steven M. Gordon, MD, Carmela.
Tracheal regeneration: Myth or fact?

Tracheal regeneration: Myth or fact?
Tracheal Replacement With a Silicone-Stented, Fresh Aortic Allograft in Sheep  Hisashi Tsukada, MD, PhD, Armin Ernst, MD, Sidhu Gangadharan, MD, Simon.

Tracheal Replacement With a Silicone-Stented, Fresh Aortic Allograft in Sheep  Hisashi Tsukada, MD, PhD, Armin Ernst, MD, Sidhu Gangadharan, MD, Simon.
Definition of proximal anastomosis in the doors study

Definition of proximal anastomosis in the doors study
In situ tissue engineering for tracheal reconstruction using a luminar remodeling type of artificial trachea  Tatsuo Nakamura, MD, Toshihiko Sato, Masato.

In situ tissue engineering for tracheal reconstruction using a luminar remodeling type of artificial trachea  Tatsuo Nakamura, MD, Toshihiko Sato, Masato.
Wen-Jian Jiang, MD, Jin-Hua Li, MD, Jiang Dai, MD, Yong-Qiang Lai, MD 

Wen-Jian Jiang, MD, Jin-Hua Li, MD, Jiang Dai, MD, Yong-Qiang Lai, MD 
Prevention of the second stage of epithelial loss is a potential novel treatment for bronchiolitis obliterans  Yunge Zhao, MD, PhD, John F. Steidle, BA,

Prevention of the second stage of epithelial loss is a potential novel treatment for bronchiolitis obliterans  Yunge Zhao, MD, PhD, John F. Steidle, BA,
Tracheal Regeneration Following Tracheal Replacement With an Allogenic Aorta  Emmanuel Martinod, MD, PhD, Agathe Seguin, MD, Muriel Holder-Espinasse, MD,

Tracheal Regeneration Following Tracheal Replacement With an Allogenic Aorta  Emmanuel Martinod, MD, PhD, Agathe Seguin, MD, Muriel Holder-Espinasse, MD,
Effects of azithromycin and tanomastat on experimental bronchiolitis obliterans  Katharina Krenn, MD, Matthias Gmeiner, MD, PhD, Patrick Paulus, MD, Nezir.

Effects of azithromycin and tanomastat on experimental bronchiolitis obliterans  Katharina Krenn, MD, Matthias Gmeiner, MD, PhD, Patrick Paulus, MD, Nezir.
Stenting of an outflow graft obstruction after implantation of a continuous-flow, axial-flow left ventricular assist device  Duc Thinh Pham, MD, Navin.

Stenting of an outflow graft obstruction after implantation of a continuous-flow, axial-flow left ventricular assist device  Duc Thinh Pham, MD, Navin.
Tracheal cartilage regeneration by slow release of basic fibroblast growth factor from a gelatin sponge  Hitoshi Igai, MD, Yasumichi Yamamoto, MD, Sung.

Tracheal cartilage regeneration by slow release of basic fibroblast growth factor from a gelatin sponge  Hitoshi Igai, MD, Yasumichi Yamamoto, MD, Sung.
Cell transplantation preserves cardiac function after infarction by infarct stabilization: Augmentation by stem cell factor  Shafie Fazel, MD, MSc, Liwen.

Cell transplantation preserves cardiac function after infarction by infarct stabilization: Augmentation by stem cell factor  Shafie Fazel, MD, MSc, Liwen.
The trachea: The first tissue-engineered organ?

The trachea: The first tissue-engineered organ?
Decellularized heart valve as a scaffold for in vivo recellularization: Deleterious effects of granulocyte colony-stimulating factor  Francis Juthier,

Decellularized heart valve as a scaffold for in vivo recellularization: Deleterious effects of granulocyte colony-stimulating factor  Francis Juthier,
Christopher G. A. McGregor, MB, William R

Christopher G. A. McGregor, MB, William R
Dorien Van Saen, Ph. D. , Ellen Goossens, Ph. D. , Joeri L. Aerts, Ph

Dorien Van Saen, Ph. D. , Ellen Goossens, Ph. D. , Joeri L. Aerts, Ph
Stem cell therapy in the aging hearts of Fisher 344 rats: Synergistic effects on myogenesis and angiogenesis  Jiang-Yong Min, MD, Yu Chen, MD, Sohail.

Stem cell therapy in the aging hearts of Fisher 344 rats: Synergistic effects on myogenesis and angiogenesis  Jiang-Yong Min, MD, Yu Chen, MD, Sohail.
Intrathoracic esophageal replacement by in situ tissue-engineered esophagus  Yuen Nakase, MD, PhD, Tatsuo Nakamura, MD, PhD, Shuichi Kin, MD, PhD, Susumu.

Intrathoracic esophageal replacement by in situ tissue-engineered esophagus  Yuen Nakase, MD, PhD, Tatsuo Nakamura, MD, PhD, Shuichi Kin, MD, PhD, Susumu.
The days of future past  Neel K. Ranganath, MD, Aubrey C. Galloway, MD 

The days of future past  Neel K. Ranganath, MD, Aubrey C. Galloway, MD 

Similar presentations

Ads by Google